Global Anti Rabies Serum Market Report 2025

Anti-Rabies Serum Global Market Report 2025 – By Type (Human Anti-rabies Immunoglobulin, Equine Anti-rabies Immunoglobulin), By Dosage And Form (Vials, Prefilled Syringes), By Route of Administration (Intravenous, Intramuscular), By End User (Hospitals, Clinics, Veterinary Hospitals) – Market Size, Trends, And Global Forecast 2025-2034

Anti-Rabies Serum Global Market Report 2025

Report Price : $4490.00 | Pages : | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Need assistance or more information before the purchase?

Enquire Before Buying
Anti-Rabies Serum Global Market Report 2025

Proud Members Of

checkslacipN checkaoirsN checkscipN

Anti-Rabies Serum Market Definition

Anti-rabies serum, also known as rabies immune globulin (RIG), refers to a medical treatment used to provide immediate passive immunity against the rabies virus. It is administered to individuals who have been exposed to the virus through bites or scratches from potentially rabid animals, typically in conjunction with the rabies vaccine. The serum contains antibodies that neutralize the virus, helping to prevent the onset of rabies, which is a fatal disease once symptoms appear.

The main types of anti-rabies serum are human anti-rabies immunoglobulin and equine anti-rabies immunoglobulin. Human rabies immune globulin (HRIG) is derived from the blood plasma of human donors who have been immunized against rabies. It is preferred due to its reduced risk of allergic reactions and compatibility with human patients. These serum comes in various dosage forms, including vials and prefilled syringes, and is administered through Intravenous and intramuscular. These are used by many end-users, including hospitals, clinics, and veterinary hospitals.

Anti-Rabies Serum Market Segmentation

The anti-rabies serum market covered in this report is segmented –

1) By Type: Human Anti-rabies Immunoglobulin, Equine Anti-rabies Immunoglobulin

2) By Dosage And Form: Vials, Prefilled Syringes

3) By Route of Administration: Intravenous, Intramuscular

4) By End User: Hospitals, Clinics, Veterinary Hospitals

Subsegments:

1) By Human Anti-Rabies Immunoglobulin: Monovalent Human Anti-Rabies Immunoglobulin, Polyvalent Human Anti-Rabies Immunoglobulin, Intramuscular Human Anti-Rabies Immunoglobulin, Intravenous Human Anti-Rabies Immunoglobulin, Freeze-Dried Human Anti-Rabies Immunoglobulin

2) By Equine Anti-Rabies Immunoglobulin: Freeze-Dried Equine Anti-Rabies Immunoglobulin, Liquid Equine Anti-Rabies Immunoglobulin, Monovalent Equine Anti-Rabies Immunoglobulin, Polyvalent Equine Anti-Rabies Immunoglobulin

Anti-Rabies Serum Market Size and growth rate 2025 to 2029: Graph

Anti-Rabies Serum Market Size 2025 And Growth Rate

The anti-rabies serum market size has grown strongly in recent years. It will grow from $1.42 billion in 2024 to $1.5 billion in 2025 at a compound annual growth rate (CAGR) of 5.7%. The growth in the historic period can be attributed to growth in animal populations, expansion of vaccination programs, improved diagnostic techniques, increased travel and migration, and rising public health initiatives, rising incidence of wildlife encounters.

Anti-Rabies Serum Market Growth Forecast

The anti-rabies serum market size is expected to see strong growth in the next few years. It will grow to $1.85 billion in 2029 at a compound annual growth rate (CAGR) of 5.4%. The growth in the forecast period can be attributed to the rising incidence of animal bites, increased funding for rabies research, rising awareness of zoonotic diseases, improvement in serum storage and handling, and enhanced support for rabies control programs. Major trends in the forecast period include the development of new serum formulations, advancements in healthcare infrastructure, technological advancements in serum production, the development of alternative delivery systems, and the development of rapid diagnostic kits.

Anti-Rabies Serum Market Driver: The Rise In The Prevalence Of Dog Bites Propelling The Growth Of The Anti-Rabies Serum Market

The rise in the prevalence of dog bites is expected to propel the growth of the anti-rabies serum market going forward. Dog bites refer to injuries caused when a dog bites or scratches a person, which can vary from minor to severe. These bites can lead to infections, serious wounds, and, in some cases, transmission of diseases such as rabies. Effective prevention and prompt medical treatment are crucial for managing and mitigating the risks associated with dog bites. The rise in the prevalence of dog bites is due to several factors, such as increased urbanization leading to more frequent interactions between people and dogs, a higher number of unrestrained or poorly trained dogs, and insufficient awareness or education about dog behavior and bite prevention. The rise in the prevalence of dog bites has led to increased demand for anti-rabies serum, as timely administration of the serum is crucial for preventing the onset of rabies in individuals exposed to potentially infected animals. For instance, in 2023, according to the American Veterinary Medical Association, a US-based non-profit organization, the average cost for dog bite insurance claims in 2023 was $58,545 Insurers paid out $1.12B in liability claims related to dog bites and other dog-related injuries in 2023. Dog bite claims increased by nearly 10% in 2023. Therefore, the rise in the prevalence of dog bites is driving the growth of the anti-rabies serum market.

Global Anti-Rabies Serum Market Major Players

Major companies operating in the anti-rabies serum market are Merck & Co Inc., Sanofi SA, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, HCX Pharmaceuticals LLP, Intas Pharmaceuticals Ltd, Bavarian Nordic AS, Serum Institute of India Pvt Ltd., Bharat Serums And Vaccines Limited, Indian Immunologicals Ltd., Bharat Biotech., National Institute of Health Islamabad, ViNS Bioproducts Ltd., Shanghai Serum Bio-technology, Premium Serums and Vaccines Pvt Ltd ., Congruent Pharmachem, Haffkine Bio Pharmaceutical Corporation Limited, LEXICARE PHARMA PVT. LTD., Avin Darou, Central Research Institute Kasauli, Vigilomed Pharmaceuticals

Global Anti-Rabies Serum Market Trend: Biopharmaceutical Partnership Aims To Prevent Rabies And Raise Disease Awareness In The US

Major companies in the anti-rabies serum market are adopting strategic partnerships to enhance product development and expand market reach. Strategic partnerships refer to a process in which companies leverage each other's strengths and resources to achieve mutual benefits and success. For instance, in July 2023, Kedrion S.p.A, a US-based biopharmaceutical company partnered with Kamada an Israel-based biopharmaceutical company to distribute KEDRAB (Rabies Immune Globulin [Human]) in the US. This collaboration has been instrumental in co-developing and licensing the product in the U.S., while also raising disease awareness. Through their efforts, the partnership has helped protect individuals exposed to rabid animal bites from serious and potentially life-threatening conditions.

Anti-Rabies Serum Market Merger And Acquisition: Ceva Santé Animale Expands Rabies Portfolio With Acquisition Of Artemis Technologies Inc.

In May 2022, Ceva Santé Animale, a France-based veterinary pharmaceutical company, acquired Artemis Technologies Inc. for an undisclosed amount. This strategic acquisition expands Ceva's rabies portfolio and strengthens its presence in North America. Artemis Technologies Inc. is a Canada-based provider of rabies glycoprotein recombinant oral vaccine.

Regional Outlook For The Global Anti-Rabies Serum Market

North America was the largest region in the anti-rabies serum market in 2024. The regions covered in the anti-rabies serum market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the anti-rabies serum market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Anti-Rabies Serum Market?

The anti-rabies serum market consists of sales of rabies monoclonal antibodies, rabies immune globulin (RIG) combination products, and human rabies immune globulin (HRIG). Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Anti-Rabies Serum Industry?

The anti-rabies serum market research report is one of a series of new reports from The Business Research Company that provides anti-rabies serum market statistics, including anti-rabies serum industry global market size, regional shares, competitors with an anti-rabies serum market share, detailed anti-rabies serum market segments, market trends and opportunities, and any further data you may need to thrive in the anti-rabies serum industry. This anti-rabies serum market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Anti Rabies Serum Market Report Forecast Analysis
Report AttributeDetails
Market Size Value In 2025 1.5 billion
Revenue Forecast In 2034 $1.85 billion
Growth Rate CAGR of 5.4% from 2024 to 2033
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered The anti-rabies serum market covered in this report is segmented –
1) By Type: Human Anti-rabies Immunoglobulin, Equine Anti-rabies Immunoglobulin
2) By Dosage And Form: Vials, Prefilled Syringes
3) By Route of Administration: Intravenous, Intramuscular
4) By End User: Hospitals, Clinics, Veterinary Hospitals Subsegments:
1) By Human Anti-Rabies Immunoglobulin: Monovalent Human Anti-Rabies Immunoglobulin, Polyvalent Human Anti-Rabies Immunoglobulin, Intramuscular Human Anti-Rabies Immunoglobulin, Intravenous Human Anti-Rabies Immunoglobulin, Freeze-Dried Human Anti-Rabies Immunoglobulin
2) By Equine Anti-Rabies Immunoglobulin: Freeze-Dried Equine Anti-Rabies Immunoglobulin, Liquid Equine Anti-Rabies Immunoglobulin, Monovalent Equine Anti-Rabies Immunoglobulin, Polyvalent Equine Anti-Rabies Immunoglobulin
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Merck & Co Inc., Sanofi SA, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, HCX Pharmaceuticals LLP, Intas Pharmaceuticals Ltd, Bavarian Nordic AS, Serum Institute of India Pvt Ltd., Bharat Serums And Vaccines Limited, Indian Immunologicals Ltd., Bharat Biotech., National Institute of Health Islamabad, ViNS Bioproducts Ltd., Shanghai Serum Bio-technology, Premium Serums and Vaccines Pvt Ltd ., Congruent Pharmachem, Haffkine Bio Pharmaceutical Corporation Limited, LEXICARE PHARMA PVT. LTD., Avin Darou, Central Research Institute Kasauli, Vigilomed Pharmaceuticals
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Anti-Rabies Serum Market Characteristics

    3. Anti-Rabies Serum Market Trends And Strategies

    4. Anti-Rabies Serum Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

    5. Global Anti-Rabies Serum Growth Analysis And Strategic Analysis Framework

    5.1. Global Anti-Rabies Serum PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

    5.2. Analysis Of End Use Industries

    5.3. Global Anti-Rabies Serum Market Growth Rate Analysis

    5.4. Global Anti-Rabies Serum Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

    5.5. Global Anti-Rabies Serum Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

    5.6. Global Anti-Rabies Serum Total Addressable Market (TAM)

    6. Anti-Rabies Serum Market Segmentation

    6.1. Global Anti-Rabies Serum Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Human Anti-rabies Immunoglobulin

    Equine Anti-rabies Immunoglobulin

    6.2. Global Anti-Rabies Serum Market, Segmentation By Dosage And Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Vials

    Prefilled Syringes

    6.3. Global Anti-Rabies Serum Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Intravenous

    Intramuscular

    6.4. Global Anti-Rabies Serum Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Hospitals

    Clinics

    Veterinary Hospitals

    6.5. Global Anti-Rabies Serum Market, Sub-Segmentation Of Human Anti-Rabies Immunoglobulin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Monovalent Human Anti-Rabies Immunoglobulin

    Polyvalent Human Anti-Rabies Immunoglobulin

    Intramuscular Human Anti-Rabies Immunoglobulin

    Intravenous Human Anti-Rabies Immunoglobulin

    Freeze-Dried Human Anti-Rabies Immunoglobulin

    6.6. Global Anti-Rabies Serum Market, Sub-Segmentation Of Equine Anti-Rabies Immunoglobulin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Freeze-Dried Equine Anti-Rabies Immunoglobulin

    Liquid Equine Anti-Rabies Immunoglobulin

    Monovalent Equine Anti-Rabies Immunoglobulin

    Polyvalent Equine Anti-Rabies Immunoglobulin

    7. Anti-Rabies Serum Market Regional And Country Analysis

    7.1. Global Anti-Rabies Serum Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    7.2. Global Anti-Rabies Serum Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8. Asia-Pacific Anti-Rabies Serum Market

    8.1. Asia-Pacific Anti-Rabies Serum Market Overview

    Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Anti-Rabies Serum Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8.3. Asia-Pacific Anti-Rabies Serum Market, Segmentation By Dosage And Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8.4. Asia-Pacific Anti-Rabies Serum Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    9. China Anti-Rabies Serum Market

    9.1. China Anti-Rabies Serum Market Overview

    9.2. China Anti-Rabies Serum Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    9.3. China Anti-Rabies Serum Market, Segmentation By Dosage And Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    9.4. China Anti-Rabies Serum Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    10. India Anti-Rabies Serum Market

    10.1. India Anti-Rabies Serum Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    10.2. India Anti-Rabies Serum Market, Segmentation By Dosage And Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    10.3. India Anti-Rabies Serum Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11. Japan Anti-Rabies Serum Market

    11.1. Japan Anti-Rabies Serum Market Overview

    11.2. Japan Anti-Rabies Serum Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11.3. Japan Anti-Rabies Serum Market, Segmentation By Dosage And Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11.4. Japan Anti-Rabies Serum Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12. Australia Anti-Rabies Serum Market

    12.1. Australia Anti-Rabies Serum Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12.2. Australia Anti-Rabies Serum Market, Segmentation By Dosage And Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12.3. Australia Anti-Rabies Serum Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13. Indonesia Anti-Rabies Serum Market

    13.1. Indonesia Anti-Rabies Serum Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13.2. Indonesia Anti-Rabies Serum Market, Segmentation By Dosage And Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13.3. Indonesia Anti-Rabies Serum Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14. South Korea Anti-Rabies Serum Market

    14.1. South Korea Anti-Rabies Serum Market Overview

    14.2. South Korea Anti-Rabies Serum Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14.3. South Korea Anti-Rabies Serum Market, Segmentation By Dosage And Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14.4. South Korea Anti-Rabies Serum Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15. Western Europe Anti-Rabies Serum Market

    15.1. Western Europe Anti-Rabies Serum Market Overview

    15.2. Western Europe Anti-Rabies Serum Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15.3. Western Europe Anti-Rabies Serum Market, Segmentation By Dosage And Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15.4. Western Europe Anti-Rabies Serum Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16. UK Anti-Rabies Serum Market

    16.1. UK Anti-Rabies Serum Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16.2. UK Anti-Rabies Serum Market, Segmentation By Dosage And Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16.3. UK Anti-Rabies Serum Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17. Germany Anti-Rabies Serum Market

    17.1. Germany Anti-Rabies Serum Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17.2. Germany Anti-Rabies Serum Market, Segmentation By Dosage And Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17.3. Germany Anti-Rabies Serum Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18. France Anti-Rabies Serum Market

    18.1. France Anti-Rabies Serum Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18.2. France Anti-Rabies Serum Market, Segmentation By Dosage And Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18.3. France Anti-Rabies Serum Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19. Italy Anti-Rabies Serum Market

    19.1. Italy Anti-Rabies Serum Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19.2. Italy Anti-Rabies Serum Market, Segmentation By Dosage And Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19.3. Italy Anti-Rabies Serum Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20. Spain Anti-Rabies Serum Market

    20.1. Spain Anti-Rabies Serum Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20.2. Spain Anti-Rabies Serum Market, Segmentation By Dosage And Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20.3. Spain Anti-Rabies Serum Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21. Eastern Europe Anti-Rabies Serum Market

    21.1. Eastern Europe Anti-Rabies Serum Market Overview

    21.2. Eastern Europe Anti-Rabies Serum Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21.3. Eastern Europe Anti-Rabies Serum Market, Segmentation By Dosage And Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21.4. Eastern Europe Anti-Rabies Serum Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22. Russia Anti-Rabies Serum Market

    22.1. Russia Anti-Rabies Serum Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22.2. Russia Anti-Rabies Serum Market, Segmentation By Dosage And Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22.3. Russia Anti-Rabies Serum Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23. North America Anti-Rabies Serum Market

    23.1. North America Anti-Rabies Serum Market Overview

    23.2. North America Anti-Rabies Serum Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23.3. North America Anti-Rabies Serum Market, Segmentation By Dosage And Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23.4. North America Anti-Rabies Serum Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24. USA Anti-Rabies Serum Market

    24.1. USA Anti-Rabies Serum Market Overview

    24.2. USA Anti-Rabies Serum Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24.3. USA Anti-Rabies Serum Market, Segmentation By Dosage And Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24.4. USA Anti-Rabies Serum Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25. Canada Anti-Rabies Serum Market

    25.1. Canada Anti-Rabies Serum Market Overview

    25.2. Canada Anti-Rabies Serum Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25.3. Canada Anti-Rabies Serum Market, Segmentation By Dosage And Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25.4. Canada Anti-Rabies Serum Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26. South America Anti-Rabies Serum Market

    26.1. South America Anti-Rabies Serum Market Overview

    26.2. South America Anti-Rabies Serum Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26.3. South America Anti-Rabies Serum Market, Segmentation By Dosage And Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26.4. South America Anti-Rabies Serum Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27. Brazil Anti-Rabies Serum Market

    27.1. Brazil Anti-Rabies Serum Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27.2. Brazil Anti-Rabies Serum Market, Segmentation By Dosage And Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27.3. Brazil Anti-Rabies Serum Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28. Middle East Anti-Rabies Serum Market

    28.1. Middle East Anti-Rabies Serum Market Overview

    28.2. Middle East Anti-Rabies Serum Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28.3. Middle East Anti-Rabies Serum Market, Segmentation By Dosage And Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28.4. Middle East Anti-Rabies Serum Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29. Africa Anti-Rabies Serum Market

    29.1. Africa Anti-Rabies Serum Market Overview

    29.2. Africa Anti-Rabies Serum Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29.3. Africa Anti-Rabies Serum Market, Segmentation By Dosage And Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29.4. Africa Anti-Rabies Serum Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    30. Anti-Rabies Serum Market Competitive Landscape And Company Profiles

    30.1. Anti-Rabies Serum Market Competitive Landscape

    30.2. Anti-Rabies Serum Market Company Profiles

    30.2.1. Merck & Co Inc. Overview, Products and Services, Strategy and Financial Analysis

    30.2.2. Sanofi SA Overview, Products and Services, Strategy and Financial Analysis

    30.2.3. GlaxoSmithKline PLC Overview, Products and Services, Strategy and Financial Analysis

    30.2.4. Takeda Pharmaceutical Company Limited Overview, Products and Services, Strategy and Financial Analysis

    30.2.5. HCX Pharmaceuticals LLP Overview, Products and Services, Strategy and Financial Analysis

    31. Anti-Rabies Serum Market Other Major And Innovative Companies

    31.1. Intas Pharmaceuticals Ltd

    31.2. Bavarian Nordic AS

    31.3. Serum Institute of India Pvt Ltd.

    31.4. Bharat Serums And Vaccines Limited

    31.5. Indian Immunologicals Ltd.

    31.6. Bharat Biotech.

    31.7. National Institute of Health Islamabad

    31.8. ViNS Bioproducts Ltd.

    31.9. Shanghai Serum Bio-technology

    31.10. Premium Serums and Vaccines Pvt Ltd.

    31.11. Congruent Pharmachem

    31.12. Haffkine Bio Pharmaceutical Corporation Limited

    31.13. LEXICARE PHARMA PVT. LTD.

    31.14. Avin Darou

    31.15. Central Research Institute Kasauli

    32. Global Anti-Rabies Serum Market Competitive Benchmarking And Dashboard

    33. Key Mergers And Acquisitions In The Anti-Rabies Serum Market

    34. Recent Developments In The Anti-Rabies Serum Market

    35. Anti-Rabies Serum Market High Potential Countries, Segments and Strategies

    35.1 Anti-Rabies Serum Market In 2029 - Countries Offering Most New Opportunities

    35.2 Anti-Rabies Serum Market In 2029 - Segments Offering Most New Opportunities

    35.3 Anti-Rabies Serum Market In 2029 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Anti-Rabies Serum Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Anti-Rabies Serum Market, Segmentation By Dosage And Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Anti-Rabies Serum Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Anti-Rabies Serum Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Anti-Rabies Serum Market, Sub-Segmentation Of Human Anti-Rabies Immunoglobulin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Anti-Rabies Serum Market, Sub-Segmentation Of Equine Anti-Rabies Immunoglobulin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Anti-Rabies Serum Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Anti-Rabies Serum Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Asia-Pacific, Anti-Rabies Serum Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Asia-Pacific, Anti-Rabies Serum Market, Segmentation By Dosage And Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Asia-Pacific, Anti-Rabies Serum Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: China, Anti-Rabies Serum Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: China, Anti-Rabies Serum Market, Segmentation By Dosage And Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: China, Anti-Rabies Serum Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: India, Anti-Rabies Serum Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: India, Anti-Rabies Serum Market, Segmentation By Dosage And Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: India, Anti-Rabies Serum Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: Japan, Anti-Rabies Serum Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: Japan, Anti-Rabies Serum Market, Segmentation By Dosage And Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Japan, Anti-Rabies Serum Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Australia, Anti-Rabies Serum Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Australia, Anti-Rabies Serum Market, Segmentation By Dosage And Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Australia, Anti-Rabies Serum Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Indonesia, Anti-Rabies Serum Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Indonesia, Anti-Rabies Serum Market, Segmentation By Dosage And Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Indonesia, Anti-Rabies Serum Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: South Korea, Anti-Rabies Serum Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: South Korea, Anti-Rabies Serum Market, Segmentation By Dosage And Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: South Korea, Anti-Rabies Serum Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: Western Europe, Anti-Rabies Serum Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: Western Europe, Anti-Rabies Serum Market, Segmentation By Dosage And Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Western Europe, Anti-Rabies Serum Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: UK, Anti-Rabies Serum Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: UK, Anti-Rabies Serum Market, Segmentation By Dosage And Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: UK, Anti-Rabies Serum Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: Germany, Anti-Rabies Serum Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: Germany, Anti-Rabies Serum Market, Segmentation By Dosage And Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Germany, Anti-Rabies Serum Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: France, Anti-Rabies Serum Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: France, Anti-Rabies Serum Market, Segmentation By Dosage And Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: France, Anti-Rabies Serum Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: Italy, Anti-Rabies Serum Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: Italy, Anti-Rabies Serum Market, Segmentation By Dosage And Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Italy, Anti-Rabies Serum Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Spain, Anti-Rabies Serum Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Spain, Anti-Rabies Serum Market, Segmentation By Dosage And Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Spain, Anti-Rabies Serum Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Eastern Europe, Anti-Rabies Serum Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Eastern Europe, Anti-Rabies Serum Market, Segmentation By Dosage And Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Eastern Europe, Anti-Rabies Serum Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Russia, Anti-Rabies Serum Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Russia, Anti-Rabies Serum Market, Segmentation By Dosage And Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Russia, Anti-Rabies Serum Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: North America, Anti-Rabies Serum Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: North America, Anti-Rabies Serum Market, Segmentation By Dosage And Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: North America, Anti-Rabies Serum Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: USA, Anti-Rabies Serum Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: USA, Anti-Rabies Serum Market, Segmentation By Dosage And Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: USA, Anti-Rabies Serum Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: Canada, Anti-Rabies Serum Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: Canada, Anti-Rabies Serum Market, Segmentation By Dosage And Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: Canada, Anti-Rabies Serum Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: South America, Anti-Rabies Serum Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: South America, Anti-Rabies Serum Market, Segmentation By Dosage And Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: South America, Anti-Rabies Serum Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: Brazil, Anti-Rabies Serum Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: Brazil, Anti-Rabies Serum Market, Segmentation By Dosage And Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Brazil, Anti-Rabies Serum Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Middle East, Anti-Rabies Serum Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Middle East, Anti-Rabies Serum Market, Segmentation By Dosage And Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Middle East, Anti-Rabies Serum Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Africa, Anti-Rabies Serum Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Africa, Anti-Rabies Serum Market, Segmentation By Dosage And Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Africa, Anti-Rabies Serum Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Merck & Co Inc. Financial Performance
  • Table 78: Sanofi SA Financial Performance
  • Table 79: GlaxoSmithKline PLC Financial Performance
  • Table 80: Takeda Pharmaceutical Company Limited Financial Performance
  • Table 81: HCX Pharmaceuticals LLP Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Anti-Rabies Serum Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Anti-Rabies Serum Market, Segmentation By Dosage And Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Anti-Rabies Serum Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Anti-Rabies Serum Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Anti-Rabies Serum Market, Sub-Segmentation Of Human Anti-Rabies Immunoglobulin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Anti-Rabies Serum Market, Sub-Segmentation Of Equine Anti-Rabies Immunoglobulin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Anti-Rabies Serum Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Anti-Rabies Serum Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Asia-Pacific, Anti-Rabies Serum Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Asia-Pacific, Anti-Rabies Serum Market, Segmentation By Dosage And Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Asia-Pacific, Anti-Rabies Serum Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: China, Anti-Rabies Serum Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: China, Anti-Rabies Serum Market, Segmentation By Dosage And Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: China, Anti-Rabies Serum Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: India, Anti-Rabies Serum Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: India, Anti-Rabies Serum Market, Segmentation By Dosage And Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: India, Anti-Rabies Serum Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: Japan, Anti-Rabies Serum Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: Japan, Anti-Rabies Serum Market, Segmentation By Dosage And Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Japan, Anti-Rabies Serum Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Australia, Anti-Rabies Serum Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Australia, Anti-Rabies Serum Market, Segmentation By Dosage And Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Australia, Anti-Rabies Serum Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Indonesia, Anti-Rabies Serum Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Indonesia, Anti-Rabies Serum Market, Segmentation By Dosage And Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Indonesia, Anti-Rabies Serum Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: South Korea, Anti-Rabies Serum Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: South Korea, Anti-Rabies Serum Market, Segmentation By Dosage And Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: South Korea, Anti-Rabies Serum Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: Western Europe, Anti-Rabies Serum Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: Western Europe, Anti-Rabies Serum Market, Segmentation By Dosage And Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Western Europe, Anti-Rabies Serum Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: UK, Anti-Rabies Serum Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: UK, Anti-Rabies Serum Market, Segmentation By Dosage And Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: UK, Anti-Rabies Serum Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: Germany, Anti-Rabies Serum Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: Germany, Anti-Rabies Serum Market, Segmentation By Dosage And Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Germany, Anti-Rabies Serum Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: France, Anti-Rabies Serum Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: France, Anti-Rabies Serum Market, Segmentation By Dosage And Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: France, Anti-Rabies Serum Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: Italy, Anti-Rabies Serum Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: Italy, Anti-Rabies Serum Market, Segmentation By Dosage And Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Italy, Anti-Rabies Serum Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Spain, Anti-Rabies Serum Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Spain, Anti-Rabies Serum Market, Segmentation By Dosage And Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Spain, Anti-Rabies Serum Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Eastern Europe, Anti-Rabies Serum Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Eastern Europe, Anti-Rabies Serum Market, Segmentation By Dosage And Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Eastern Europe, Anti-Rabies Serum Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Russia, Anti-Rabies Serum Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Russia, Anti-Rabies Serum Market, Segmentation By Dosage And Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Russia, Anti-Rabies Serum Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: North America, Anti-Rabies Serum Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: North America, Anti-Rabies Serum Market, Segmentation By Dosage And Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: North America, Anti-Rabies Serum Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: USA, Anti-Rabies Serum Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: USA, Anti-Rabies Serum Market, Segmentation By Dosage And Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: USA, Anti-Rabies Serum Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: Canada, Anti-Rabies Serum Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: Canada, Anti-Rabies Serum Market, Segmentation By Dosage And Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: Canada, Anti-Rabies Serum Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: South America, Anti-Rabies Serum Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: South America, Anti-Rabies Serum Market, Segmentation By Dosage And Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: South America, Anti-Rabies Serum Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: Brazil, Anti-Rabies Serum Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: Brazil, Anti-Rabies Serum Market, Segmentation By Dosage And Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Brazil, Anti-Rabies Serum Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Middle East, Anti-Rabies Serum Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Middle East, Anti-Rabies Serum Market, Segmentation By Dosage And Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Middle East, Anti-Rabies Serum Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Africa, Anti-Rabies Serum Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Africa, Anti-Rabies Serum Market, Segmentation By Dosage And Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Africa, Anti-Rabies Serum Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Merck & Co Inc. Financial Performance
  • Figure 78: Sanofi SA Financial Performance
  • Figure 79: GlaxoSmithKline PLC Financial Performance
  • Figure 80: Takeda Pharmaceutical Company Limited Financial Performance
  • Figure 81: HCX Pharmaceuticals LLP Financial Performance
View Report
View Report
View Report
View Report
View Report
View Report
View Report
View Report

Frequently Asked Questions

What is the definition of the Anti-Rabies Serum market?

Anti-rabies serum, also known as rabies immune globulin (RIG), refers to a medical treatment used to provide immediate passive immunity against the rabies virus. It is administered to individuals who have been exposed to the virus through bites or scratches from potentially rabid animals, typically in conjunction with the rabies vaccine. The serum contains antibodies that neutralize the virus, helping to prevent the onset of rabies, which is a fatal disease once symptoms appear. For further insights on the Anti-Rabies Serum market, request a sample here

How will the Anti-Rabies Serum market drivers and restraints affect the market dynamics? What forces will shape the Anti-Rabies Serum industry going forward?

The Anti-Rabies Serum market major growth driver - The Rise In The Prevalence Of Dog Bites Propelling The Growth Of The Anti-Rabies Serum Market. For further insights on the Anti-Rabies Serum market, request a sample here

What is the forecast market size or the forecast market value of the Anti-Rabies Serum market?

The Anti-Rabies Serum market size has grown strongly in recent years. The anti-rabies serum market size has grown strongly in recent years. It will grow from $1.42 billion in 2024 to $1.5 billion in 2025 at a compound annual growth rate (CAGR) of 5.7%. The growth in the historic period can be attributed to growth in animal populations, expansion of vaccination programs, improved diagnostic techniques, increased travel and migration, and rising public health initiatives, rising incidence of wildlife encounters. The anti-rabies serum market size is expected to see strong growth in the next few years. It will grow to $1.85 billion in 2029 at a compound annual growth rate (CAGR) of 5.4%. The growth in the forecast period can be attributed to the rising incidence of animal bites, increased funding for rabies research, rising awareness of zoonotic diseases, improvement in serum storage and handling, and enhanced support for rabies control programs. Major trends in the forecast period include the development of new serum formulations, advancements in healthcare infrastructure, technological advancements in serum production, the development of alternative delivery systems, and the development of rapid diagnostic kits. For further insights on the Anti-Rabies Serum market, request a sample here

How is the Anti-Rabies Serum market segmented?

The anti-rabies serum market covered in this report is segmented –
1) By Type: Human Anti-rabies Immunoglobulin, Equine Anti-rabies Immunoglobulin
2) By Dosage And Form: Vials, Prefilled Syringes
3) By Route of Administration: Intravenous, Intramuscular
4) By End User: Hospitals, Clinics, Veterinary Hospitals Subsegments:
1) By Human Anti-Rabies Immunoglobulin: Monovalent Human Anti-Rabies Immunoglobulin, Polyvalent Human Anti-Rabies Immunoglobulin, Intramuscular Human Anti-Rabies Immunoglobulin, Intravenous Human Anti-Rabies Immunoglobulin, Freeze-Dried Human Anti-Rabies Immunoglobulin
2) By Equine Anti-Rabies Immunoglobulin: Freeze-Dried Equine Anti-Rabies Immunoglobulin, Liquid Equine Anti-Rabies Immunoglobulin, Monovalent Equine Anti-Rabies Immunoglobulin, Polyvalent Equine Anti-Rabies Immunoglobulin For further insights on the Anti-Rabies Serum market,
request a sample here

Which region has the largest share of the Anti-Rabies Serum market? What are the other regions covered in the report?

North America was the largest region in the anti-rabies serum market in 2024. The regions covered in the anti-rabies serum market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the Anti-Rabies Serum market, request a sample here.

Who are the major players in the Anti-Rabies Serum market?

Major companies operating in the anti-rabies serum market are Merck & Co Inc., Sanofi SA, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, HCX Pharmaceuticals LLP, Intas Pharmaceuticals Ltd, Bavarian Nordic AS, Serum Institute of India Pvt Ltd., Bharat Serums And Vaccines Limited, Indian Immunologicals Ltd., Bharat Biotech., National Institute of Health Islamabad, ViNS Bioproducts Ltd., Shanghai Serum Bio-technology, Premium Serums and Vaccines Pvt Ltd ., Congruent Pharmachem, Haffkine Bio Pharmaceutical Corporation Limited, LEXICARE PHARMA PVT. LTD., Avin Darou, Central Research Institute Kasauli, Vigilomed Pharmaceuticals . For further insights on the Anti-Rabies Serum market, request a sample here.

What are the key trends in the Anti-Rabies Serum market?

Major trends in the Anti-Rabies Serum market include Biopharmaceutical Partnership Aims To Prevent Rabies And Raise Disease Awareness In The US. For further insights on the Anti-Rabies Serum market, request a sample here.

What are the major opportunities in the Anti-Rabies Serum market? What are the strategies for the Anti-Rabies Serum market?

For detailed insights on the major opportunities and strategies in the Anti-Rabies Serum market, request a sample here.

How does the Anti-Rabies Serum market relate to the overall economy and other similar markets?

For detailed insights on Anti-Rabies Serum's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the Anti-Rabies Serum industry?

For detailed insights on the mergers and acquisitions in the Anti-Rabies Serum industry, request a sample here.

What are the key dynamics influencing the Anti-Rabies Serum market growth? SWOT analysis of the Anti-Rabies Serum market.

For detailed insights on the key dynamics influencing the Anti-Rabies Serum market growth and SWOT analysis of the Anti-Rabies Serum industry, request a sample here.